Cancer will affect roughly one in every three people at some point in their lives, and improving its prevention, early detection, and treatment remains a major challenge for medical science. The Hutchison/MRC Research Centre is a state-of-the-art cancer research facility built in 2001 by capital funding from the Medical Research Council (MRC), and a generous donation to the University of Cambridge from Hutchison Whampoa Ltd. The Hutchison/MRC Research Centre is now a leading site for basic and translational cancer research in Cambridge.
The MRC Cancer Unit’s mission is to advance understanding of the earliest steps in the development of cancer, and use this knowledge to improve the early detection of cancer, to identify individuals who are most at risk of developing cancer, and to develop new approaches for the treatment of cancer, through the creation of innovative technologies.
The Department of Oncology aims to deliver the best possible care to patients, provide a world-class environment for academic and clinical research, and generate world-leading scientists and doctors through our education and training programmes. Our research focusses on developing new ways to diagnose, treat and prevent cancer.
The Hutchison/MRC Research Centre houses active clinicians as well as basic scientists, enabling the rapid translation of discoveries made at the research bench into clinically viable applications at the patient’s bedside. Our work is facilitated by our location on the Cambridge Biomedical Campus, enabling fruitful interactions with colleagues in the NHS, the CRUK Cambridge Institute, an outstanding cohort of neighbouring MRC Units and Institutes, and in the clinical and basic science departments of the University of Cambridge.
For more information on the constituent parts of the Research Centre, visit the MRC Cancer Unit and the